Home › Multiple Myeloma › California › Mountain View
Multiple Myeloma clinical trials in Mountain View, CA
10 studies for Multiple Myeloma are looking for participants at sites in and around Mountain View (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study Evaluating the Prophylactic Use of Tocilizumab to Prevent Cytokine Release Syndrome With Ramantamig Administration in Participants With Relapsed/Refractory Multiple Myeloma
RecruitingPhase 2
- Stanford University Medical Center, Palo Alto · 5 mi away
A Long-term Study for Participants Previously Treated With Ciltacabtagene Autoleucel
RecruitingPhase 4
- Stanford University Medical Center, Stanford · 5 mi away
Study to Assess Safety and Tolerability of OPN-6602 in Subjects With Relapsed and/or Refractory Multiple Myeloma
RecruitingPhase 1
- Stanford Cancer Institute, Stanford · 5 mi away
A Phase III, Multicentre Study to Evaluate Consolidation Treatment With AZD0120 Compared With ASCT, in Participants With Newly Diagnosed Multiple Myeloma Who Are Transplant Eligible (DURGA-6).
RecruitingPhase 3
- Research Site, Stanford · 5 mi away
TAPUR: Testing the Use of Food and Drug Administration (FDA) Approved Drugs That Target a Specific Abnormality in a Tumor Gene in People With Advanced Stage Cancer
RecruitingPhase 2
- Sutter Palo Alto Medical Foundation: Palo Alto, Palo Alto · 5 mi away
A Study to Evaluate a Novel Gene Therapy in Patients With Relapsed and Refractory Multiple Myeloma
RecruitingPhase 1
- Stanford University, Palo Alto · 5 mi away
Talquetamab & Lenalidomide as Post Stem Cell Transplant Maintenance in Multiple Myeloma
RecruitingPhase 2
- Stanford University, Palo Alto · 5 mi away
Study of ISB 2001 in Relapsed/Refractory Multiple Myeloma (TRIgnite-1)
RecruitingPhase 1
- Standford Cancer Institute, Palo Alto · 5 mi away
A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)
RecruitingPhase 1/2
- Stanford University, Palo Alto · 5 mi away
A Study to Assess BMS-986453 in Participants With Relapsed and/or Refractory Multiple Myeloma
RecruitingPhase 1
- Stanford University Medical Center, Stanford · 5 mi away
About Multiple Myeloma
Multiple myeloma is a cancer that begins in plasma cells, a type of white blood cell. Discover symptoms, diagnostic tests, and treatments for myeloma.
More about Multiple Myeloma on MedlinePlus
Multiple Myeloma trials in other cities
- New York City, NY59 studies
- Boston, MA45 studies
- Atlanta, GA42 studies
- Houston, TX39 studies
- Durham, NC36 studies
- Nashville, TN31 studies
- Denver, CO26 studies
- St. Louis, MO26 studies
- Rochester, MN25 studies
- Columbus, OH25 studies
- Chicago, IL24 studies
- Milwaukee, WI23 studies
Other studies in Mountain View
- Cancer (all types)38 studies
- Breast Cancer27 studies
- Non-Small Cell Lung Cancer26 studies
- Metastatic Cancer24 studies
- Lung Cancer20 studies
- Acute Myeloid Leukemia19 studies
- Ovarian Cancer19 studies
- Autism Spectrum Disorder17 studies
- Prostate Cancer15 studies
- Acute Lymphoblastic Leukemia14 studies
- Heart Failure14 studies
- Autism13 studies
From ClinicalTrials.gov, data retrieved Nov 15, 2026. Each study sets its own eligibility; the study team decides who can join.